TOX and melanoma: Our scRNA-seq data showed that transcripts for inhibitory KIRs were specifically enriched in Vδ1 cells, especially in the subpopulation that also displayed high co-expression of ICR genes and TOX. KIR gene expression correlated mostly with cells derived from patients with melanoma and it was downregulated following successful mono- or combination therapy.